Literature DB >> 2942160

Coronary artery thrombus as a risk factor for acute vessel occlusion during percutaneous transluminal coronary angioplasty: improving results.

D D Sugrue, D R Holmes, H C Smith, G S Reeder, G E Lane, R E Vlietstra, J F Bresnahan, L N Hammes, J M Piehler.   

Abstract

Early experience with percutaneous transluminal coronary angioplasty (from October 1979 to March 1983 inclusive) showed that pre-existing coronary artery thrombus was associated with a significant increase in the incidence of acute coronary occlusion during angioplasty. Acute occlusion occurred in 11 (73%) of 15 patients with pre-existing thrombus compared with 18 (8%) of 223 patients without thrombus. The effect of improved technology (steerable guiding systems) and altered dilatation strategy (full intravenous heparinisation for 24 hours after the procedure and more intensive use of antiplatelet medications) was studied by review of angiograms from 297 consecutive patients without evidence of acute myocardial infarction who underwent angioplasty from April 1983 to March 1985 inclusive. Coronary artery thrombus was present in 34 (11%) patients, eight (24%) of whom had complete occlusion during or immediately after the procedure compared with 34 (13%) of 263 patients without thrombus. Patients with pre-existing coronary artery thrombus continue to be at greater risk of complete occlusion than patients without thrombus, but this risk has declined significantly since the modification of the angioplasty procedure.

Entities:  

Mesh:

Year:  1986        PMID: 2942160      PMCID: PMC1277386          DOI: 10.1136/hrt.56.1.62

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  12 in total

Review 1.  Secondary prevention after myocardial infarction: a review of short-term acute phase trials.

Authors:  G S May; C D Furberg; K A Eberlein; B J Geraci
Journal:  Prog Cardiovasc Dis       Date:  1983 Jan-Feb       Impact factor: 8.194

2.  Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute.

Authors:  K M Kent; L G Bentivoglio; P C Block; M J Cowley; G Dorros; A J Gosselin; A Gruntzig; R K Myler; J Simpson; S H Stertzer; D O Williams; L Fisher; M J Gillespie; K Detre; S Kelsey; S M Mullin; M B Mock
Journal:  Am J Cardiol       Date:  1982-06       Impact factor: 2.778

3.  Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry.

Authors:  G Dorros; M J Cowley; J Simpson; L G Bentivoglio; P C Block; M Bourassa; K Detre; A J Gosselin; A R Grüntzig; S F Kelsey; K M Kent; M B Mock; S M Mullin; R K Myler; E R Passamani; S H Stertzer; D O Williams
Journal:  Circulation       Date:  1983-04       Impact factor: 29.690

4.  Angiographic occurrence and clinical correlates of intraluminal coronary artery thrombus: role of unstable angina.

Authors:  D R Bresnahan; J L Davis; D R Holmes; H C Smith
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

5.  Angiographic morphology and the pathogenesis of unstable angina pectoris.

Authors:  J A Ambrose; S L Winters; A Stern; A Eng; L E Teichholz; R Gorlin; V Fuster
Journal:  J Am Coll Cardiol       Date:  1985-03       Impact factor: 24.094

6.  Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

Authors:  J A Cairns; M Gent; J Singer; K J Finnie; G M Froggatt; D A Holder; G Jablonsky; W J Kostuk; L J Melendez; M G Myers
Journal:  N Engl J Med       Date:  1985-11-28       Impact factor: 91.245

7.  Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty.

Authors:  T A Mabin; D R Holmes; H C Smith; R E Vlietstra; A A Bove; G S Reeder; J H Chesebro; J F Bresnahan; T A Orszulak
Journal:  J Am Coll Cardiol       Date:  1985-02       Impact factor: 24.094

8.  Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris.

Authors:  J B Mandelkorn; N M Wolf; S Singh; J A Shechter; R I Kersh; D M Rodgers; M B Workman; L G Bentivoglio; S M LaPorte; S G Meister
Journal:  Am J Cardiol       Date:  1983-07       Impact factor: 2.778

9.  Percutaneous transluminal coronary angioplasty: initial Mayo Clinic experience.

Authors:  R E Vlietstra; D R Holmes; H C Smith; G O Hartzler; T A Orszulak
Journal:  Mayo Clin Proc       Date:  1981-05       Impact factor: 7.616

10.  Coronary artery thrombosis in patients with unstable angina.

Authors:  D R Holmes; G O Hartzler; H C Smith; V Fuster
Journal:  Br Heart J       Date:  1981-04
View more
  5 in total

1.  Adjunctive Therapy with an Antithrombotic Drug Can Prevent Reocclusion and Induce Residual Thrombus Reduction After Percutaneous Transcatheter Angioplasty of the Thrombotic Lesions.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Induction of thrombolysis and prevention of thrombus formation by local drug delivery with a double-occlusion balloon catheter.

Authors:  T Tomaru; Y Fujimori; F Nakamura; N Aoki; Y Sakamoto; K Kawai; M Omata; Y Uchida
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

Review 3.  Coronary angioscopy.

Authors:  C J White; S R Ramee; T J Collins; J P Murgo
Journal:  Tex Heart Inst J       Date:  1995

4.  Percutaneous Transluminal Coronary Angioplasty for Unstable Angina: Predictors of Outcome in a Multicenter Study.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

5.  Angiographic Morphology Following Heparin and Aspirin Therapy in Patients with Acute Coronary Syndromes and Intracoronary Thrombus.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.